slides · global inventory
Analyze Data
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 58,039
Current window 31,201-31,230
Pages 1,935
Rows per page 30
Slide function
31,201-31,230 of 58,039
36
Includes a primary chart and a smaller inset chart for comparison.Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
37
Includes a primary chart and a smaller inset chart showing similar data for different dosage levels.Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
38
The chart displays mean values with SEM error bars for various THC doses and ANEB-001 treatment groups.Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
39
The slide displays PK data on both linear and log scales to demonstrate dose-related exposure and half-life characteristics.Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
40
The slide compares six different treatment arms across two scales to demonstrate dose-related exposure.Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
07
Includes box plot showing 10th/90th percentiles and line chart showing concentration over 20 minutes.Aquestive Therapeutics | Results Presentation Deck | 14 slides · Aquestive Therapeutics
Deck Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
08
Box plot showing baseline adjusted epinephrine Tmax.Aquestive Therapeutics | Results Presentation Deck | 14 slides · Aquestive Therapeutics
Deck Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
09
Shows rapid onset of therapeutic benefits for AQST-109.Aquestive Therapeutics | Results Presentation Deck | 14 slides · Aquestive Therapeutics
Deck Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
10
Clinical trial data comparing sublingual/oral film (AQST-109) vs intramuscular injection.Aquestive Therapeutics | Results Presentation Deck | 14 slides · Aquestive Therapeutics
Deck Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
11
The chart shows box plots for baseline adjusted Epinephrine Cmax, highlighting differences in drug exposure between the two treatment groups.Aquestive Therapeutics | Results Presentation Deck | 14 slides · Aquestive Therapeutics
Deck Investor relations Beat · Solution (Provide relief)1 hit
14
Includes specific clinical metrics (ORR, mPFS, mOS) comparing patients above and below the Minimal Efficacious Concentration (MEC).Aravive | Investor Presentation Deck | 39 slides · Aravive
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
15
The slide includes two scatter plots with error bars and two summary tables of experimental data.Aravive | Investor Presentation Deck | 39 slides · Aravive
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
23
The slide includes detailed footnotes explaining specific adverse events and patient outcomes.Aravive | Investor Presentation Deck | 39 slides · Aravive
Pitch deck Investor relations 1 hit
25
Data compares low vs high biomarker groups across different dosage cohorts.Aravive | Investor Presentation Deck | 39 slides · Aravive
Pitch deck Investor relations 1 hit
30
Data cutoff date is August 18, 2022. N=21 patients.Aravive | Investor Presentation Deck | 39 slides · Aravive
Pitch deck Investor relations 1 hit
32
Swimmer plot showing patient IDs on y-axis and weeks on study on x-axis, with various clinical status markers.Aravive | Investor Presentation Deck | 39 slides · Aravive
Pitch deck Investor relations 1 hit
33
Data shows a clear correlation between achieving MEC and better clinical outcomes in PDAC patients.Aravive | Investor Presentation Deck | 39 slides · Aravive
Pitch deck Investor relations 1 hit
15
Includes clinical trial data (Study 301) and registry survival analysis.AstraZeneca | Investor Day Presentation Deck | 49 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution & ApproachLoop · Mece Breakdown1 hit
17
Includes three distinct data visualizations: a bar chart for median MG-ADL, a box plot for change from baseline, and a line chart for mean MG-ADL over time.AstraZeneca | Investor Day Presentation Deck | 49 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution & ApproachLoop · Mece Breakdown1 hit
18
Includes 'Number at risk' table below the x-axis.AstraZeneca | Investor Day Presentation Deck | 49 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution & ApproachLoop · Mece Breakdown1 hit
20
The slide uses a combination of a timeline/map graphic and a bar chart to demonstrate market penetration and adoption speed.AstraZeneca | Investor Day Presentation Deck | 49 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & ProofLoop · Quick Win Big Bet1 hit
16
CADSS = Clinician Administered Dissociative States Scale. Data points represent individual patient scores over time.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
24
The ARPR chart includes a specific annotation regarding the FY21 COVID-related impact.Auto Trader Group | Investor Day Presentation Deck | 100 slides · Auto Trader
Conference presentation Investor relations 1 hit
25
The chart excludes COVID-related discounts. The data is segmented by three categories: Price Lever, Stock Lever, and Product Lever.Auto Trader Group | Investor Day Presentation Deck | 100 slides · Auto Trader
Conference presentation Investor relations 1 hit
26
The slide uses a stacked bar chart to show profit pools and a table to show yield percentages.Auto Trader Group | Investor Day Presentation Deck | 100 slides · Auto Trader
Conference presentation Investor relations 1 hit
28
The chart uses a stacked bar approach where the solid blue represents current penetration and the hatched area represents future growth potential.Auto Trader Group | Investor Day Presentation Deck | 100 slides · Auto Trader
Conference presentation Investor relations 1 hit
31
Uses a combination of stacked bar, column, and line charts to validate market growth assumptions.Auto Trader Group | Investor Day Presentation Deck | 100 slides · Auto Trader
Conference presentation Investor relations 1 hit
32
The chart uses a color shift to distinguish historical data from the forecast period.Auto Trader Group | Investor Day Presentation Deck | 100 slides · Auto Trader
Conference presentation Investor relations 1 hit
34
The slide uses a combination of stacked bar charts for penetration and a combo chart (bar + line) for PCH volumes.Auto Trader Group | Investor Day Presentation Deck | 100 slides · Auto Trader
Conference presentation Investor relations 1 hit
35
The chart highlights the 2030 milestone for the end of new petrol and diesel car sales.Auto Trader Group | Investor Day Presentation Deck | 100 slides · Auto Trader
Conference presentation Investor relations 1 hit